Abstract:Individual genome scans for quantitative trait loci (QTL) mapping often suffer from low statistical power and imprecise estimates of QTL location and effect. This lack of precision yields large confidence intervals for QTL location, which are problematic for subsequent fine mapping and positional cloning. In prioritizing areas for follow-up after an initial genome scan and in evaluating the credibility of apparent linkage signals, investigators typically examine the results of other genome scans of the same phenotype and informally update their beliefs about which linkage signals in their scan most merit confidence and follow-up via a subjective-intuitive integration approach. A method that acknowledges the wisdom of this general paradigm but formally borrows information from other scans to increase confidence in objectivity would be a benefit. We developed an empirical Bayes analytic method to integrate information from multiple genome scans. The linkage statistic obtained from a single genome scan study is updated by incorporating statistics from other genome scans as prior information. This technique does not require that all studies have an identical marker map or a common estimated QTL effect. The updated linkage statistic can then be used for the estimation of QTL location and effect. We evaluate the performance of our method by using extensive simulations based on actual marker spacing and allele frequencies from available data. Results indicate that the empirical Bayes method can account for between-study heterogeneity, estimate the QTL location and effect more precisely, and provide narrower confidence intervals than results from any single individual study. We also compared the empirical Bayes method with a method originally developed for meta-analysis (a closely related but distinct purpose). In the face of marked heterogeneity among studies, the empirical Baycs method outperforms the comparator.

BayesQuantify: an R package utilized to refine the ACMG/AMP criteria according to the Bayesian framework

Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework

PERCH: A Unified Framework for Disease Gene Prioritization

The PS4-likelihood ratio calculator: flexible allocation of evidence weighting for case-control data in variant classification

Quantitative thresholds for variant enrichment in 13,845 cases: improving pathogenicity classification in genetic hearing loss

AutoPM3: Enhancing Variant Interpretation via LLM-driven PM3 Evidence Extraction from Scientific Literature

BayMeth: improved DNA methylation quantification for affinity capture sequencing data using a flexible Bayesian approach

Challenges and approaches to calibrating patient phenotype as evidence for cancer gene variant classification under ACMG/AMP guidelines

MagicalRsq: Machine-learning-based Genotype Imputation Quality Calibration.

When Two plus Four Does Not Equal Six: Combining Computational and Functional Evidence Towards Classification of BRCA1 Key Domain Missense Substitutions.

Sherloc: a comprehensive refinement of the ACMG–AMP variant classification criteria

An Empirical Bayes Method For Updating Inferences In Analysis Of Quantitative Trait Loci Using Information From Related Genome Scans

Automating ACMG Variant Classifications Using BIAS-2015: An Algorithm Overview and Benchmark Against the FDA-Approved eRepo Dataset

QAFI: a novel method for quantitative estimation of missense variant impact using protein-specific predictors and ensemble learning

ClinGen Variant Curation Interface: a variant classification platform for the application of evidence criteria from ACMG/AMP guidelines

ClinGen guidance for use of the PP1/BS4 co-segregation and PP4 phenotype specificity criteria for sequence variant pathogenicity classification

mbQTL: an R/Bioconductor package for microbial quantitative trait loci (QTL) estimation

A tutorial on aggregating evidence from conceptual replication studies using the product Bayes factor

Functional Integrative Bayesian Analysis of High-dimensional Multiplatform Genomic Data

Evaluation of Bayesian Point-Based System on the Variant Classification of Hereditary Cancer Predisposition Genes